| abstract |
The present application describes disubstituted pyrazolines and triazolines of formulae I and II:or pharmaceutically acceptable salt forms thereof, wherein one of M1 and M2 maybe N and D may be a variety of N-containing groups, which are useful as inhibitors of factor Xa. |